LanZhou Foci Pharmaceutical Co.,Ltd. (SHE:002644)
China · Delayed Price · Currency is CNY 9.93
+0.28 (2.90%)
Feb 4, 2026, 2:45 PM CST
SHE:002644 Revenue
LanZhou Foci Pharmaceutical had revenue of 194.69M CNY in the quarter ending September 30, 2025, a decrease of -7.14%. This brings the company's revenue in the last twelve months to 895.75M, down -9.41% year-over-year. In the year 2024, LanZhou Foci Pharmaceutical had annual revenue of 980.23M, down -15.73%.
Revenue (ttm)
895.75M
Revenue Growth
-9.41%
P/S Ratio
5.50
Revenue / Employee
657.67K
Employees
1,362
Market Cap
4.93B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 980.23M | -182.91M | -15.73% |
| Dec 31, 2023 | 1.16B | 120.75M | 11.58% |
| Jan 1, 2023 | 1.04B | 224.75M | 27.49% |
| Jan 1, 2022 | 817.64M | 149.59M | 22.39% |
| Dec 31, 2020 | 668.05M | 39.24M | 6.24% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jinling Pharmaceutical Company | 3.13B |
| Tianjin Tianyao Pharmaceuticals | 2.87B |
| Zhejiang Starry Pharmaceutical | 2.39B |
| Yabao Pharmaceutical Group | 2.27B |
| Ningbo Menovo Pharmaceutical | 1.54B |
| Zhuhai Rundu Pharmaceutical | 1.19B |
| Tibet Weixinkang Medicine | 1.17B |
| Shandong Wohua Pharmaceutical | 816.95M |